Advanced or Metastatic Gastric Cancer in Elderly Patients: Clinicopathological, Prognostic Factors and Treatments

Overview

Journal Clin Transl Oncol

Specialty Oncology

Date 2012 Oct 12

PMID 23054754

Citations 7

Authors

Z Lu

M Lu

J Zhou

J Gong

J Gao

J Li

X Zhang

Y Li

L Shen

Affiliations

Soon will be listed here.

Abstract

Purpose: To analyze the clinicopathological features, prognostic factors, treatment efficacy and safety among elderly patients with advanced or metastatic gastric cancer.

Methods: Three hundred and nineteen patients aged 65 years and older, diagnosed with advanced or metastatic gastric cancer, were followed and data were retrospectively collected, reviewed and analyzed.

Results: The elderly patients carried specific clinicopathological characteristics. Body mass index (BMI), number of metastatic lesions, ascites, Karnofsky performance score (KPS), tumor differentiation grade, lactate dehydrogenase (LDH) level, local treatment, and chemotherapy were the independent prognostic factors. Serum LDH level was superior to the serum CEA level in the prognosis of advanced or metastatic gastric cancer in older patients. Cisplatin-based regimen, chemotherapy cycles, metastatic lesions, LDH level, and supraclavicular lymph node metastasis were the independent prognostic factors in 220 patients receiving chemotherapy. The toxicity was mild and tolerable.

Conclusion: KPS, BMI and a well-differentiated histopathology were factors favoring longer survival, whereas elevated serum LDH and a greater number of metastatic lesions were associated with poor prognosis among those elderly patients. Cisplatin-based chemotherapy provided survival benefits and mild toxicity.

Citing Articles

Prognostic significance of lactate dehydrogenase and its impact on the outcomes of gastric cancer: a systematic review and meta-analysis.

Chen J, Zou X Front Oncol. 2023; 13:1247444.

PMID: 37727205 PMC: 10505930. DOI: 10.3389/fonc.2023.1247444.

Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery.

Ren X, Huang T, Tang X, Ma Q, Zheng Y, Hu Z Front Oncol. 2023; 13:1223857.

PMID: 37655111 PMC: 10466399. DOI: 10.3389/fonc.2023.1223857.

Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow's Node Involvement.

Wedin M, Tsoli M, Wallin G, Janson E, Koumarianou A, Kaltsas G Cancers (Basel). 2022; 14(4).

PMID: 35205660 PMC: 8869999. DOI: 10.3390/cancers14040913.

[Factors affecting survival prognosis of advanced gastric cancer and establishment of a nomogram predictive model].

Zhang L, Liu X, Lin H, Wang J, Zhang Q Nan Fang Yi Ke Da Xue Xue Bao. 2021; 41(4):621-627.

PMID: 33963725 PMC: 8110451. DOI: 10.12122/j.issn.1673-4254.2021.04.21.

Optimal treatment for elderly patients with resectable proximal gastric carcinoma: a real world study based on National Cancer Database.

Wang X, Zhao J, Fairweather M, Yang T, Sun Y, Wang J BMC Cancer. 2019; 19(1):1079.

PMID: 31706283 PMC: 6842542. DOI: 10.1186/s12885-019-6166-3.

References

Munoz N, Franceschi S . Epidemiology of gastric cancer and perspectives for prevention. Salud Publica Mex. 1997; 39(4):318-30. DOI: 10.1590/s0036-36341997000400010. View

Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjoden P, Haglund U . Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 1997; 8(2):163-8. DOI: 10.1023/a:1008243606668. View

Santini D, Graziano F, Catalano V, Di Seri M, Testa E, Baldelli A . Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. BMC Cancer. 2006; 6:125. PMC: 1475875. DOI: 10.1186/1471-2407-6-125. View

Graziano F, Santini D, Testa E, Catalano V, Beretta G, Mosconi S . A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer. Br J Cancer. 2003; 89(8):1428-32. PMC: 2394359. DOI: 10.1038/sj.bjc.6601280. View

Kamangar F, Dores G, Anderson W . Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24(14):2137-50. DOI: 10.1200/JCO.2005.05.2308. View

Ishigami S, Natsugoe S, Saihara T, Hokita S, TOKUSHIGE M, Watanabe T . Clinical and pathologic features of early gastric cancer in elderly patients. Hepatogastroenterology. 1997; 44(16):1164-8. View

Chau I, Norman A, Cunningham D, Waters J, Oates J, Ross P . Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol. 2004; 22(12):2395-403. DOI: 10.1200/JCO.2004.08.154. View

Wu C, Lo S, Shen K, Hsieh M, Lui W, Peng F . Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly. World J Surg. 2000; 24(4):465-72. DOI: 10.1007/s002689910074. View

Wang J, Hsieh J, Huang C, Huang Y, Huang T . Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients. J Surg Oncol. 1996; 63(1):36-40. DOI: 10.1002/(SICI)1096-9098(199609)63:1<36::AID-JSO6>3.0.CO;2-R. View

10.

Tsuji A, Shima Y, Morita S, Uchida M, Okamoto K, Morita M . Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study. Anticancer Res. 2008; 28(2B):1433-8. View

11.

Sudo H, Takagi Y, Katayanagi S, Hoshino S, Suda T, Hibi Y . [Bone metastasis of gastric cancer]. Gan To Kagaku Ryoho. 2006; 33(8):1058-60. View

12.

Cascinu S, Scartozzi M, Labianca R, Catalano V, Silva R, Barni S . High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive.... Br J Cancer. 2004; 90(8):1521-5. PMC: 2409717. DOI: 10.1038/sj.bjc.6601752. View

13.

Habu H, Endo M . Gastric cancer in elderly patients--results of surgical treatment. Hepatogastroenterology. 1989; 36(2):71-4. View

14.

Arai T, Takubo K . Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly. Pathol Int. 2007; 57(6):303-14. DOI: 10.1111/j.1440-1827.2007.02101.x. View

15.

Murad A, Santiago F, Petroianu A, Rocha P, Rodrigues M, Rausch M . Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer. 1993; 72(1):37-41. DOI: 10.1002/1097-0142(19930701)72:1<37::aid-cncr2820720109>3.0.co;2-p. View

16.

Lee J, Kang Y, Kang H, Lee K, Zang D, Ryoo B . A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer. Br J Cancer. 2008; 99(4):584-90. PMC: 2527839. DOI: 10.1038/sj.bjc.6604536. View

17.

Seol Y, Song M, Choi Y, Kim G, Shin H, Song G . Oral fluoropyrimidines (capecitabine or S-1) and cisplatin as first line treatment in elderly patients with advanced gastric cancer: a retrospective study. Jpn J Clin Oncol. 2008; 39(1):43-8. DOI: 10.1093/jjco/hyn119. View

18.

Saif M, Makrilia N, Zalonis A, Merikas M, Syrigos K . Gastric cancer in the elderly: an overview. Eur J Surg Oncol. 2010; 36(8):709-17. DOI: 10.1016/j.ejso.2010.05.023. View

19.

Arai T, Esaki Y, Inoshita N, Sawabe M, Kasahara I, Kuroiwa K . Pathologic characteristics of gastric cancer in the elderly: a retrospective study of 994 surgical patients. Gastric Cancer. 2004; 7(3):154-9. DOI: 10.1007/s10120-004-0285-4. View

20.

Cascinu S, Labianca R, Alessandroni P, Marcellini M, Silva R, Pancera G . Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. J Clin Oncol. 1997; 15(11):3313-9. DOI: 10.1200/JCO.1997.15.11.3313. View